Comparison of Tear Evaporation Rate With DAILIES TOTAL1 and Biotrue ONEday
NCT ID: NCT04037969
Last Updated: 2021-04-23
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2019-08-07
2019-11-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DAILIES TOTAL1® - Comparative Assessment of Tear Film Evaporation
NCT02517567
A Prospective Study of Two Daily Disposable Contact Lenses
NCT01636986
Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact Lenses
NCT01634659
Effect of Contact Lenses on Tear Osmolarity in a Controlled Low Humidity Chamber
NCT01482312
Clinical Evaluation of DAILIES TOTAL 1® Performance in a Japanese Population
NCT02710292
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nesofilcon A/Delefilcon A
Nesofilcon A was worn in right eye and delefilcon A worn in the left eye.
Nesofilcon A
Hydrogel contact lens for daily wear
Delefilcon A
Silicone hydrogel contact lens for daily wear
Delefilcon A/Nesofilcon A
Delefilcon A was worn in right eye and Nesofilcon A worn in the left eye.
Nesofilcon A
Hydrogel contact lens for daily wear
Delefilcon A
Silicone hydrogel contact lens for daily wear
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nesofilcon A
Hydrogel contact lens for daily wear
Delefilcon A
Silicone hydrogel contact lens for daily wear
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Has read and signed an information consent letter;
3. Is willing and able to follow instructions and maintain the appointment schedule;
4. Has worn soft contact lenses for a minimum of 6 months;
5. Currently wears soft contact lenses for at least 4 days per week and 8 hours per day;
6. Has an acceptable fit and comfort with both study contact lenses in the powers available;
7. Has less than or equal to 1.00DS difference between eyes in their habitual contact lenses;
8. Is willing to be awake for at least 2 hours before visit 2;
9. Is willing to not wear eye makeup on the day of visit 2 and 3;
10. Is willing to not use eye drops or artificial tears on the day of visits 1, 2, and 3;
11. Has a wearable pair of spectacles.
Exclusion Criteria
2. Has any known active\* ocular disease and/or infection;
3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
5. Has known sensitivity to sodium fluorescein dye;
6. Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit);
7. Is aphakic;
8. Has undergone refractive error surgery;
9. Has a known sensitivity to petroleum jelly (Vaseline);
10. Has epilepsy and/or a sensitivity to flashing lights;
11. Wears toric contact lenses;
12. Has any physical impairment that would interfere with holding the evaporimeter;
13. Has taken part in another research study within the last 14 days.
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Waterloo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre for Ocular Research & Education
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
41195
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.